Next upHack for Humanity: San Francisco (powered by Google Gemini)
News

ServiceNow launches autonomous-security suite built on Armis and Veza acquisitions

ServiceNow launched a suite of autonomous-security products built on its Armis and Veza acquisitions, targeting enterprise machine-identity sprawl.

D
Aug 4, 2026 · 1 min read

ServiceNow launched a suite of autonomous-security products on Aug. 4, built on its Armis and Veza acquisitions. The company pitched agentic AI as a way to manage the sprawl of machine identities inside large enterprises.

ServiceNow framed the problem in its own numbers: the average enterprise runs more than 70 security tools, and the number of machine identities – the credentials attached to software, services and now AI agents rather than people – doubles roughly every 18 months. ServiceNow said its platform processes more than 100 billion workflows a year.

The newsworthy pieces are the ones aimed at AI itself. AI Agent Access Security and Non-Human Identity Remediation are meant to govern the credentials that autonomous agents use, a category security teams have struggled to track. An Agentic Exposure Management product rounds out the set, alongside application-security, attack-surface and cryptographic-compliance offerings folded into the same suite.

Seven offerings are available now; four more, including a Tier 2 SOC AI Specialist and a Vulnerability Resolution AI Specialist, are due in December 2026. Yevgeny Dibrov, ServiceNow’s senior vice president and general manager of cybersecurity and risk, said the lineup is meant to consolidate fragmented security tooling, and Brandon Glaze of Baker Hughes endorsed the Armis integration.

The figures on tool counts and identity growth are ServiceNow’s own, offered as marketing rationale rather than independent research, and the December products cannot yet be evaluated. Machine-identity management is a genuine gap as enterprises begin deploying AI agents with real system access, so the pitch lands on a real problem even if the products remain unproven.

More news